As physician advocates, we are proud of our commitment to and alignment with the world-class arrhythmia program at Kansas City Heart Rhythm Institute and thank them for their continued support of our technology.' Lakkireddy and the physician faculty at Overland Park. Londoner, Chairman and CEO of BioSig Technologies, Inc. 'The Company is excited about our clinical collaboration with Dr. 'We are pleased to announce our first purchase agreement since we transformed the commercial capabilities under new management,' said Kenneth L.

As a Company that prioritizes physician experience and throughput, we believe a leasing program supports the clinical evolution of PURE EP as we continue upgrading and enhancing our technology based on physician feedback.' 'Establishing a contract with a leading national hospital network is a milestone achievement for BioSig Technologies,' commented Gray Fleming, Chief Commercialization Officer, BioSig Technologies, Inc. 'A leasing option provides a cost-effective and efficient pathway for hospitals to acquire our technology. The agreement also represents The Company's first national purchasing agreement. The agreement represents BioSig's first commercial adoption since it announced the national launch of its PURE EP System, supported by The Company's new commercial structure and clinical support teams.

has signed a purchase agreement to acquire its PURE EP(T.M.) System.įollowing its evaluation of BioSig's PURE EP System, Overland Park Regional Medical Center (OPRMC) has signed an agreement to purchase the technology under the terms of the Company's new program. JBioSig Technologies, Inc., a medical technology company advancing electrophysiology workflow by delivering greater intracardiac signal fidelity through its proprietary signal processing platform, today announced that Kansas City Heart Institute at Overland Park Regional Medical Center in Kansas City, U.S.

Quest diagnostics las vegas